4-(1H-Imidazol-1-yl)aniline
4-(1H-Imidazol-1-yl)aniline Basic information
- Product Name:
- 4-(1H-Imidazol-1-yl)aniline
- Synonyms:
-
- ART-CHEM-BB B021935
- 1-(4-AMINOPHENYL)IMIDAZOLE
- 1-(4'-AMINOPHEN-1-YL)IMIDAZOLE
- 1-(4-AMINOPHENYL)-1H-IMIDAZOLE
- 4-(IMIDAZOL-1-YL)-ANILINE
- 4-IMIDAZOL-1-YL-PHENYLAMINE
- 4-(1H-IMIDAZOL-1-YL)ANILINE
- AKOS B021935
- CAS:
- 2221-00-3
- MF:
- C9H9N3
- MW:
- 159.19
- Product Categories:
-
- Heterocyclic Compounds
- Amines
- Phenyls & Phenyl-Het
- pharmacetical
- Imidazol&Benzimidazole
- Mol File:
- 2221-00-3.mol
4-(1H-Imidazol-1-yl)aniline Chemical Properties
- Melting point:
- 143-147 °C(lit.)
- Boiling point:
- 355.4±25.0 °C(Predicted)
- Density
- 1.20±0.1 g/cm3(Predicted)
- storage temp.
- Keep in dark place,Inert atmosphere,Room temperature
- form
- powder
- pka
- 6.05±0.10(Predicted)
- CAS DataBase Reference
- 2221-00-3(CAS DataBase Reference)
MSDS
- Language:English Provider:SigmaAldrich
4-(1H-Imidazol-1-yl)aniline Usage And Synthesis
Chemical Properties
White powder
Uses
LANA-IN-1 (compound 8) is an N-acetyl-derived LANA inhibitor with antiviral activity against herpesvirus. In fluorescence assays using the LANA probe LBS2, 1 mM LANA-IN-1 shows an inhibition rate of 32%. LANA-IN-1 may inhibit the interaction between LANA and the viral genome[1].
Synthesis
288-32-4
106-40-1
2221-00-3
GENERAL METHODS: In a catalyzed reaction, Catalyst C1 (12 mg, 0.01 mmol), imidazole (1.0 mmol), 4-bromoaniline (1.0 mmol), NaOH (80 mg, 2.0 mmol), and dimethyl sulfoxide (DMSO, 5 mL) were added to a sealed tube. The reaction mixture was stirred at 100 °C for 4 h and subsequently cooled to room temperature. After the reaction was completed, 5 mL of water was added and the mixture was extracted with ethyl acetate (5 mL x 3). The organic layers were combined, dried with anhydrous Na2SO4 and concentrated under reduced pressure to remove the solvent. Finally, the target product 4-(imidazol-1-yl)aniline was purified by silica gel column chromatography.
References
[1] Kirsch P, et al. Fragment-Based Discovery of a Qualified Hit Targeting the Latency-Associated Nuclear Antigen of the Oncogenic Kaposi's Sarcoma-Associated Herpesvirus/Human Herpesvirus 8. J Med Chem. 2019 Apr 25;62(8):3924-3939. DOI:10.1021/acs.jmedchem.8b01827
4-(1H-Imidazol-1-yl)anilineSupplier
- Tel
- 18210857532; 18210857532
- jkinfo@jkchemical.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
- Tel
- +86 (0) 571 85 58 67 18
- Tel
- 021-54306202 13764082696
- info@hanhongsci.com
- Tel
- 4009903999 13355009207
- 3007715519@qq.com
4-(1H-Imidazol-1-yl)aniline(2221-00-3)Related Product Information
- N-Phenylglycinonitrile
- Aniline
- Acid Blue 93
- Imidazole
- 4-(4,5-Dichloro-1H-imidazol-1-yl)aniline, 95+%,4-(4,5-DICHLORO-1H-IMIDAZOL-1-YL)ANILINE
- BOC-HIS(DNP)-OH
- 1-(4-Nitrophenyl)-1H-imidazole
- 2-(1H-BENZO[D]IMIDAZOL-2-YL)ANILINE
- 4-(4-Methyl-1H-imidazol-1-yl)benzenamine
- 5-FLUORO-2-(1H-IMIDAZOL-1-YL)ANILINE
- 3-Fluoro-4-(4-methyl-1H-imidazol-1-yl)benzenamine
- 3-(1h-imidazol-1-yl)aniline
- FMOC-HIS(DNP)-OH
- BIS(2,4-DINITROPHENYL)-L-HISTIDINE
- BOC-D-HIS(DNP)-OH IPOH
- 4,5-DICHLORO-1-(4-NITROPHENYL)IMIDAZOLE
- N-(4-(4,5-DICHLOROIMIDAZOLYL)PHENYL)(2-(4-CHLOROPHENOXY)(3-PYRIDYL))FORMAMIDE
- RO 15-4513